Subject to change.
Subject to change.
Nicolas Giraldo, Senior Director of Oncology Diagnostics, is a board-certified pathologist with subspecialty training in molecular pathology and over 15 years of experience in academia and industry. His work focuses on translating biomarkers from discovery to real-world clinical use through computational pathology, multimodal diagnostics, and precision medicine. At AstraZeneca, he leads scientific affairs efforts to advance patient stratification for next-generation cancer therapies.